Nitric oxide contracts longitudinal smooth muscle of opossum oesophagus via excitation-contraction coupling

J Physiol. 2001 Oct 1;536(Pt 1):133-40. doi: 10.1111/j.1469-7793.2001.00133.x.

Abstract

1. The effects of sodium nitroprusside (SNP) and diethylenetriamine/nitric oxide adduct (DETA/NO), putative nitric oxide (NO) donors, on opossum oesophageal longitudinal smooth muscle were investigated using isometric tension and intracellular micro-electrode recordings. 2. SNP produced concentration-dependent contractions of oesophageal longitudinal smooth muscle with an EC(50) of 239.6 +/- 78.2 microM (mean +/- S.E.M., n = 10). Maximal contraction induced by SNP (1 mM) was about 75.5 +/- 8.5 % (n = 10) of the 60 mM KCl-induced contraction. The SNP-induced contraction was resistant to tetrodotoxin (TTX; 1 microM), but abolished by nifedipine (1 microM), as well as by niflumic acid (300 microM) and 9-anthroic acid (9-AC; 1 mM), Ca(2+)-activated Cl(-) channel blockers. 3. DETA/NO at concentrations of 100 and 500 microM induced 83.1 +/- 24.4 and 104.1 +/- 34.9 % of the 60 mM KCl-induced contraction (n = 4), respectively, which was abolished by nifedipine (1 microM), niflumic acid (300 microM) and 9-AC (1 mM). 4. Pre-application of 1H-[1,2,4]oxidiazolo[4,3,-alpha]quinoxalin-1-one (ODQ) (10 microM), a guanylate cyclase inhibitor, significantly inhibited the SNP-induced contraction, whereas 8-bromo-cGMP (1 mM), a membrane-permeable analogue of cGMP, mimicked the SNP-induced contraction. 5. Intracellular recordings revealed that SNP (300 microM) depolarized resting membrane potentials (RMPs) and increased the frequency of spontaneous spike-like action potentials. However, these electrical alterations were eliminated by pretreatment with niflumic acid (300 microM). 6. These results suggest that NO produces an excitation-contraction coupling in opossum oesophageal longitudinal smooth muscle via a cGMP-dependent signalling pathway. This contraction depends on extracellular Ca(2+) entry through activation of L-type Ca(2+) channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Local / pharmacology
  • Animals
  • Calcium Channel Blockers / pharmacology
  • Cyclic GMP / metabolism
  • Enzyme Inhibitors / pharmacology
  • Esophagus / physiology*
  • Female
  • In Vitro Techniques
  • Isometric Contraction / drug effects
  • Isometric Contraction / physiology*
  • Male
  • Microelectrodes
  • Muscle, Smooth / physiology*
  • Nifedipine / pharmacology
  • Nitric Oxide / metabolism*
  • Nitric Oxide Donors / pharmacology
  • Nitroprusside / pharmacology
  • Opossums
  • Oxadiazoles / pharmacology
  • Quinoxalines / pharmacology
  • Signal Transduction / physiology
  • Tetrodotoxin / pharmacology
  • Triazenes / pharmacology

Substances

  • 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene
  • 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
  • Anesthetics, Local
  • Calcium Channel Blockers
  • Enzyme Inhibitors
  • Nitric Oxide Donors
  • Oxadiazoles
  • Quinoxalines
  • Triazenes
  • Nitroprusside
  • Nitric Oxide
  • Tetrodotoxin
  • Cyclic GMP
  • Nifedipine